Document is current
Any future updates will be listed below
-
Authors
Smits, Febe
Groen, Kaz
Korst, Charlotte L. B. M.
Frerichs, Kris A.
Kuipers, Ilse
Kruyswijk, Sandy https://orcid.org/0009-0005-6836-055X
de Ruijter, Maaike E. M.
Nasserinejad, Kazem https://orcid.org/0000-0002-5666-5015
Zweegman, Sonja
van de Donk, Niels W. C. J. https://orcid.org/0000-0002-7445-2603
- License Information
-
More Information
Article History
Received: 26 July 2025
Revised: 18 December 2025
Accepted: 9 February 2026
First Online: 21 February 2026
Competing interests
: KG has received payment/honoraria for presentations from Bristol Myers Squibb and Beigene (no personal funding). KN is employed by CSL Behring as a contractor. SZ has received research funding from Takeda, Celgene, and Janssen. SZ participates in advisory boards of Takeda, Celgene, Janssen, Sanofi, Oncopeptides, and Amgen, all paid to the employer. NWCJvdD has received research support from Janssen Pharmaceuticals, AMGEN, Celgene, Novartis, Cellectis, and Bristol Myers Squibb. He serves on advisory boards for Janssen Pharmaceuticals, AMGEN, Celgene, Bristol Myers Squibb, Takeda, Roche, Novartis, Bayer, Pfizer, Merck, Kite Pharma, AbbVie, Adaptive, and Servier, all paid to the employer. All other authors have no conflicts of interest to disclose.
